Mode
Text Size
Log in / Sign up

Sepsis

Part of Systemic Inflammatory Response Syndrome

Subtypes of Sepsis

Sepsis-associated acute lung injury 2 Burn sepsis 1 Campylobacter bacteremia 1 Intra-abdominal sepsis 1 Maternal mortality/sepsis 1 Non-associated liver injury in sepsis 1 Pulmonary sepsis 1 Salmonella bacteremia 1 Sepsis-associated acute gastrointestinal injury 1 Sepsis-Associated Hypotension 1 Sepsis-associated thrombocytopenia 1 Sepsis-induced acute gastrointestinal injury 1 Sepsis-Induced Cardiomyopathy 1 Sepsis-Induced Coagulopathy 1 Sepsis-related intestinal injury 1 Sepsis-related liver injury 1 Gram-negative bacteremia 0 Group A Streptococcus Bacteremia 0 MRSA bacteremia 0

76 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Sepsis

70 trials tracked for Sepsis: 17 in phase 3 or 4 and 9 with published results. The most-cited published study has 778 citations.

70Trials tracked
17Phase 3 & 4
0Recruiting
9With published results
Phase distribution
Phase 4 5 Phase 3 12 Phase 2 13 Phase 1 6 Other / NA 34
  1. Phase 3 Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Completed · 778 cited
  2. Phase 3 The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure Completed · 274 cited
  3. Phase 3 Vitamin C, Thiamine, and Steroids in Sepsis Completed · 274 cited
  4. Phase 3 Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial Completed · 248 cited
  5. Phase 3 A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension Completed · 234 cited
  6. Phase 4 Effect of Antibiotic Choice On ReNal Outcomes (ACORN) Completed · 125 cited
Show 44 more trials
  1. Phase 3 Zambia Chlorhexidine Application Trial Completed · 82 cited
  2. Phase 3 Vitamin C and Septic Shock Completed · 61 cited
  3. Phase 3 Feasibility of 5% Albumin Compared With Balanced Crystalloid, as Intravenous Fluid Resuscitation in Adult Patients With Sepsis, Presenting as an Emergency to Hospital Completed · 19 cited
  4. Phase 4 Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure Completed
  5. Phase 4 Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients Completed
  6. Phase 4 Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock Completed
  7. Phase 4 Effect of Nebulized Bronchodilators on Heart Rate Completed
  8. Phase 3 Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock Completed
  9. Phase 3 The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial Completed
  10. Phase 3 Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis Completed
  11. Phase 3 Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis Completed
  12. Phase 2 Ascorbic Acid (Vitamin C) Infusion in Human Sepsis Completed
  13. Phase 2 Thiamine as a Renal Protective Agent in Septic Shock Completed
  14. Phase 2 Inulin for Infections in the Intensive Care Unit Completed
  15. Phase 2 Ubiquinol (Reduced COQ10) for Patients With Sepsis Completed
  16. Phase 2 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants Completed
  17. Phase 2 Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis Completed
  18. Phase 2 GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults Completed
  19. Phase 2 Immunomodulatory Properties of Ketamine in Sepsis Completed
  20. Phase 2 Prophylactic Probiotics to Extremely Low Birth Weight Prematures Completed
  21. Phase 2 Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury Completed
  22. Phase 2 Vitamin C & Thiamine to Treat Sepsis and Septic Shock Completed
  23. Phase 2 Early Insulin and Development of ARDS Completed
  24. Phase 2 Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery Completed
  25. Phase 1 Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome Completed
  26. Phase 1 An Open Label Study to Describe the Pharmacokinetics of Daptomycin in Infants Completed
  27. Phase 1 Amendment of rTSST-1 Variant Vaccine Phase 1 Clinical Trial Completed
  28. Phase 1 Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance Completed
  29. Phase 1 Imipenem/Cilastatin/Relebactam PK in ECMO Completed
  30. Phase 1 Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates Completed
  31. N/A Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients Completed
  32. N/A Protocolized Care for Early Septic Shock Completed
  33. N/A Piperacillin PK Analysis in Severe Sepsis Patients Completed
  34. N/A A Randomized Controlled Trial of a Conservative Fluid Balance Strategy for Patients With Sepsis and Cardiopulmonary Dysfunction (BALANCE Study) Completed
  35. N/A AION BIOSYSTEMS, INC. Tempshield for Continuous Tempreature Monitoring Completed
  36. N/A Effect of Emergency Department Care Reorganization on Door-to-antibiotic Times for Sepsis (LDS SWARM) Completed
  37. N/A Impact of Heart Rate Characteristics Monitoring in Neonates Completed
  38. N/A Preemptive Resuscitation for Eradication of Septic Shock Completed
  39. N/A Extracardiac Complications After Cardiac Surgery Completed
  40. N/A Efficacy of Betalactam Antibiotics in Prolonged Infusion Compared to Intermittent in Pediatric Patients With Sepsis Completed
  41. N/A The Effect of Etomidate on Patient Outcomes After Single Bolus Doses Completed
  42. N/A Release of Nociceptin From Granulocytes in Sepsis Completed
  43. N/A Mechanistic Inflammatory Sub-study Embedded Within the Albumin vs Balanced Crystalloid Trial Completed
  44. N/A Utility of Presepsin in Distinguishing Between Sepsis and SIRS Completed

Showing the 50 most-cited and recently-updated of 70 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Systemic Inflammatory Response Syndrome

Related studies from across the Systemic Inflammatory Response Syndrome family.

Azithromycin reduces maternal infection in laboring women in low- and middle-income countries
Infectious Disease RCT
Azithromycin reduces maternal infection in laboring women in low- and middle-income countries Antibiotic reduces maternal infection risk in labor
This secondary analysis of an RCT found that azithromycin reduced maternal infection and sepsis in women in labor, with a larger reduction a…
A single dose of azithromycin during labor lowered maternal infections in a large trial across seven countries.
Systematic Review and Meta-Analysis Finds IL-27 Superior to CRP for Neonatal Sepsis Diagnosis
Pediatrics Meta-analysis
Systematic Review and Meta-Analysis Finds IL-27 Superior to CRP for Neonatal Sepsis Diagnosis A New Blood Test May Spot Newborn Sepsis Faster Than Current Methods
This systematic review and meta-analysis of 495 neonates compared IL-27 to C-reactive protein for diagnosing neonatal sepsis. IL-27 showed h…
A simple blood marker called IL-27 catches newborn sepsis more accurately than the standard test, potentially saving lives by speeding up di…
7-Day Antibiotic Regimen Non-Inferior to 14-Day for Uncomplicated Neonatal Sepsis in RCT
Pediatrics RCT
7-Day Antibiotic Regimen Non-Inferior to 14-Day for Uncomplicated Neonatal Sepsis in RCT Can shorter antibiotics cure newborn sepsis just as well as two weeks of treatment?
This randomized control assessor-blinded trial evaluated 140 neonates weighing ≥ 1000 g with culture-positive sepsis in a tertiary Neonatal …
A 7-day antibiotic course for newborn sepsis worked as well as 14 days, with babies leaving the hospital sooner and needing less breathing s…
AMR strategies in LMIC newborns reduce antibiotic use and mortality in meta-analysis
Pediatrics Meta-analysis
AMR strategies in LMIC newborns reduce antibiotic use and mortality in meta-analysis Strategies to reduce antibiotic resistance may lower infection risks in newborns in low-income countries
A systematic review and meta-analysis of 31 facility-based studies in LMICs found that strategies to reduce antimicrobial resistance, includ…
Strategies to curb antibiotic resistance in newborns in low-income countries lower infection risks and reduce overall mortality.
Maternal preeclampsia modestly increases neonatal sepsis risk in infants up to 28 days of age
Pediatrics Meta-analysis
Maternal preeclampsia modestly increases neonatal sepsis risk in infants up to 28 days of age A Mother’s High Blood Pressure May Raise Her Newborn’s Infection Risk
This systematic review and meta-analysis evaluated 1,513,008 neonates to assess the association between maternal preeclampsia and neonatal s…
Babies born to mothers with preeclampsia face a 27% higher risk of serious infection in the first month of life, prompting doctors to watch …
Case-control study identifies K. pneumoniae proteins associated with lack of neonatal sepsis
Infectious Disease Case-Control
Case-control study identifies K. pneumoniae proteins associated with lack of neonatal sepsis Study identifies potential vaccine targets for deadly newborn infection in Africa
A case-control study of 100 mother-baby dyads in sub-Saharan Africa analyzed antibody responses to 161 K.
Specific bacterial proteins might protect newborns from deadly sepsis via maternal antibodies, paving the way for a vaccine in sub-Saharan A…
Chlorhexidine May Reduce Neonatal Mortality and Infection in LMICs
Pediatrics Meta-analysis
Chlorhexidine May Reduce Neonatal Mortality and Infection in LMICs Can antiseptics on the umbilical cord save newborns from infection and death?
Meta-analysis shows 4.0% chlorhexidine reduces neonatal mortality (RR 0.86) and omphalitis (RR 0.71) in LMICs, but delays cord separation by…
Applying chlorhexidine to the umbilical cord may lower the risk of infection and death in newborns in low-income countries.

Questions about Sepsis

Does using procalcitonin to guide my sepsis care lower my chance of dying?

Yes, procalcitonin-guided care may lower your chance of dying from sepsis, with studies showing reduced 28-day and long-term mortality.

Full answer →
What quality indicators should I expect for my sepsis care in China?

In China, sepsis care quality indicators include timely antibiotic administration, blood culture collection, lactate measurement, and fluid resuscitation, as outlined in a Delphi consensus study.

Full answer →
Does having sepsis mean I will face long-term cognitive or physical problems?

Yes, sepsis survivors often face long-term cognitive, physical, and psychological problems known as post-sepsis syndrome, with impairments persisting for months to years.

Full answer →

All Sepsis Articles